MedPath

Effects of deep brain stimulation of the nucleus accumbens on the dopaminergic activity in patients with Gilles-de-la-Tourette-syndrome

Conditions
The participants under study are recruited from a sample of patients suffering from a severe form of the Gilles-de-la-Tourette-syndrome who are waiting to receive deep-brain stimulation of the ncl. accumbens as therapeutic treatment.
Registration Number
EUCTR2006-005567-26-DE
Lead Sponsor
niversity of Aachen
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Authorised-recruitment may be ongoing or finished
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

1. only patients will be included who hav acceded to undergo deep brain stimulation for treatment of their Tourette-syndrome;
2. as a consequence of 1. patients will
-be over 18 years of age
-have a certain diagnosis of GTS
-have a severe, chronic and medically refractory form of GTS
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

1. existence of other physical or neurological indispositions that might interfere with the study parameters or provide a risk to the patient in the course of the study
2. pregnancy
3. propofol hypersensitivity
4. incapability of giving consent personally

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Main Objective: Monitoring effects of deep brain stimulation of the ncl. accumbens on the dopamine transmission in patients with Gilles-de-la-tourette.;Secondary Objective: To study the correlation between dopamine transmission and symptome severity.;Primary end point(s): Dopamine transmission as quantified by [18F]Fallypride-PET
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath